2024 saw a significant increase in the total fines imposed in abuse of dominance cases compared to 2023, reversing a trend of decline in recent years. The rise in fine volumes was spread across all regions of the world, with...more
Digital regulation continues to be at the forefront of regulator concerns, as authorities focus on technology companies through traditional antitrust tools and new digital markets regimes. Further legislation and guidance is...more
In 2024, regulators across the globe increasingly acknowledged the need for a nuanced enforcement approach to balancing support for sustainability initiatives against traditional antitrust enforcement and countering the risk...more
3/21/2025
/ Antitrust Provisions ,
Competition ,
Environmental Policies ,
Environmental Social & Governance (ESG) ,
EU ,
European Commission ,
Federal Trade Commission (FTC) ,
Greenwashing ,
Popular ,
Sustainability ,
UK
Overall, global fines for cartel activity in 2024 (USD602.5 million) were the lowest recorded for several years, and significantly lower than the 2023 total (USD1.9billion). Unlike in previous years, 2024 saw relatively few...more
2024 saw a significant increase in overall global fines for antitrust enforcement, with total penalties for the jurisdictions surveyed in our report at USD6.7 billion, over double that of 2023 (USD2.9bn) and substantially...more
3/20/2025
/ Anti-Competitive ,
Antitrust Provisions ,
Antitrust Violations ,
Cartels ,
Competition ,
Enforcement Actions ,
EU ,
European Commission ,
Fines ,
Popular ,
Unfair Competition
2024 saw a continued trend of heightened dawn raid activity by antitrust authorities across the globe. Of the 31 jurisdictions surveyed, 24 (77%) confirmed that the regulator had carried out dawn raids during the course of...more
3/19/2025
/ Antitrust Violations ,
Bid Rigging ,
Competition ,
Competition Authorities ,
Dawn Raids ,
Enforcement Actions ,
EU ,
European Commission ,
Regulatory Authority ,
UK ,
UK Competition and Markets Authority (CMA)
A visual breakdown of the geographical trends in antitrust enforcement fines around the world.
Europe -
At the country level, antitrust enforcement fines in Europe were USD2.3 billion, a significant increase from...more
3/19/2025
/ Antitrust Division ,
Antitrust Provisions ,
Asia Pacific ,
Cartels ,
Competition ,
Dispute Resolution ,
Enforcement Actions ,
EU ,
European Commission ,
Fines ,
Mergers ,
Regulatory Agenda ,
Regulatory Requirements ,
United States
2024 saw a significant increase in overall global fines for antitrust enforcement, with total penalties for the jurisdictions surveyed in our report at USD6.7 billion, over double that of 2023 (USD2.9bn) and substantially...more
3/19/2025
/ Abuse of Dominance ,
Antitrust Provisions ,
Antitrust Violations ,
Artificial Intelligence ,
Asia Pacific ,
Big Tech ,
Cartels ,
Competition ,
Damages ,
Digital Assets ,
Digital Markets Strategy ,
Dispute Resolution ,
Enforcement Actions ,
EU ,
European Commission ,
Fines ,
Regulatory Agenda ,
Regulatory Reform ,
Regulatory Requirements ,
South Africa ,
Sustainability ,
Technology Sector ,
UK ,
United States
Chief executive of the U.K. Competition and Markets Authority (CMA), Sarah Cardell, has announced that the authority will launch a review of its approach to merger remedies in early 2025.
Most notably, this will include a...more
This newsletter is a summary of the antitrust developments we think are most interesting to your business. Thomas Masterman, partner based in London, is our editor this month. He has selected:
Out now: our latest global...more
4/2/2024
/ Acquisitions ,
Antitrust Division ,
Antitrust Provisions ,
Capital Markets ,
Cartels ,
Competition ,
Department of Justice (DOJ) ,
Enforcement Actions ,
EU ,
European Commission ,
Federal Trade Commission (FTC) ,
Global Market ,
Investment ,
Mergers ,
Private Equity ,
Private Equity Firms ,
Regulatory Agenda ,
Regulatory Reform ,
UK ,
UK Competition and Markets Authority (CMA)
The European Commission (EC) has fined five pharmaceutical companies a total of EUR13.4 million for participating in a cartel concerning N-Butylbromide Scopolamine/Hyoscine (SNBB) – an active pharmaceutical ingredient (API)...more
10/23/2023
/ Cartels ,
Cephalon ,
Competition ,
Corporate Counsel ,
EU ,
European Commission ,
Generic Drugs ,
Life Sciences ,
Patents ,
Pay-For-Delay ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs ,
Teva Pharmaceuticals
On 20 October 2022, an adviser (Advocate General) to the European Court of Justice (ECJ) recommended that the ECJ uphold the European Commission (EC)’s appeal of a 2020 judgment by the lower-tier General Court (GC), which set...more
On 26 November 2020, the European Commission (Commission) issued a decision fining pharmaceutical companies Teva and Cephalon EUR60.5 million for infringing Article 101 TFEU by agreeing to delay the entry of a cheaper generic...more